I am a bit surprised that we are not at least over the $3 mark, similar price point as 2018 on expecting news with partnering of Trof.
Approaching the end of phase 3 trial for the actual partnered deal, looking at potential success, closing in on potential revenue, potential $$ ROW, news front on a number of fronts.
NZ-2591 is now well progressed adding value since 2018 now heading into funded phase 2 trials.
Analysts coverage $3.60 p/sh few months back now.
Still cheap $284m MC,
I am a bit surprised that we are not at least over the $3 mark,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |